Laurion Capital Management LP Bio Atla, Inc. Transaction History

Laurion Capital Management LP

  • $11.4 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$2.13 - $5.38 $623,238 - $1.57 Million
292,600 New
292,600 $834,000
Q2 2021

Aug 13, 2021
SELL
$38.07 - $56.17 $761,400 - $1.12 Million
-20,000 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$31.02 - $35.16 $620,400 - $703,199
20,000 New
20,000 $680,000

Others Institutions Holding BCAB

# of Institutions
88
Shares Held
24.8M
Call Options Held
140K
Put Options Held
4.6K
View Full List

About BioAtla, Inc.

BCAB Quotes by TradingView
  • Ticker BCAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,304,100
  • Market Cap $47.9M
  • Description
  • BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...
More about BCAB
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email